secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2025-03-18T23:59:59+00:00
Accession:  0001819790-25-000035
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus closes public offering of 3.23M shares; net proceeds $134.8M
-------------------------------------------------------------------

- Underwriters exercised full over-allotment; total shares sold: 3,230,336 (incl. 421,348 additional shares).
- Shares sold to underwriters at $41.83 each; public offering price $44.50.
- Net proceeds of ~$134.8M after underwriting discounts and estimated offering expenses.
- Offering closed on March 14, 2025; use of proceeds not specified but typical for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979025000035/0001819790-25-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979025000035/tars-20250314.htm
  HTML page:      https://secwatch.observer/filing/0001819790-25-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer